SUPPORTED BY
About
NRMD (National Regenerative Medicine Database) は日本から世界へ、臨床研究から製造販売後調査等までのあらゆるフェーズをカバーする再生医療等製品の研究開発を支援するデータベースです。
Operated as a public-private sector collaboration, the NRMD supports the safe, steady, and speedy development of regenerative medicine.
NRMDは、臨床研究と製造販売後調査等のための法規制要件や実施基準を満たす高品質なシステムを提供します。
Introductory Video
Benefits
MERIT 01Enables to utilize control groups of various cases.
現状、再生医療の臨床研究や製造販売後調査等を行うためには移植のような介入があるため、コントロールグループを設定するのが難しい場合が多々あります。
- NRMDには治験を含む臨床研究のデータや製造販売後調査等フェーズのデータをさまざまな領域で登録しており、対照群としてデータを活用することが可能
- NRMD is constructed in cooperation with The Japanese Association of Medical Sciences, it enables to confirm the case registrations of facilities and doctors, and to make a recommendation for registration
- You can significantly reduce the cost and workload for registering control groups
- When certain results are obtained in clinical research including clinical trials,
results are officially accredited from Japan Society for Regenerative Medicine,
by the database committee, putting together the results constructed within the society
MERIT 02It can be used for certification of facilities by the Japan Society for Regenerative Medicine, and a registration requirement for a certified doctor.
It is difficult to gain credibility in the regenerative medicine, as its visibility is low among patients.
- You can disclose your facility as positive for the construction of Real World Evidence
- You can raise credibility with clear approach to regenerative medicine
- It can be certificated as an NRMD facility by Japan Society for Regenerative Medicine*Currently under consideration
- You can meet the qualification requirements of a regenerative medicine certified physician*Currently under consideration
Achivements
participating organizations and companies
CONTACT USCONTACT
The Japanese Society for Regenerative Medicine Database Committee aims to further develop and improve the NRMD based on user feedback. We welcome any inquiries or opinions - if you wish to use the database or have any questions, please contact us.
SUPPORTED BY